Jamalone™ platform transforms the unique resilience of camel biology into a modular platform for advanced therapeutics - combining nanobody precision, peptide intelligence, and clean chemistry to deliver safer, smarter biologics.
Jamalone™ platform transforms the unique resilience of camel biology into a modular platform for advanced therapeutics - combining nanobody precision, peptide intelligence, and clean chemistry to deliver safer, smarter biologics.
Camels thrive in heat, dehydration, and metabolic scarcity that disable most mammals. Their physiology couples extreme stress resilience with unique immune features – including heavy-chain-only antibodies (nanobodies) that are naturally small, stable, and tissue‑permeable. Jamalone™ harnesses this toolkit to inform drug design, delivery, and durability.
Drug payload, targeted conjugation
Computational design & optimization
Blood-brain barrier (BBB), conjugated nanobodies, targeted cell target
Biodistribution studies, efficacy & safety testing
Cell-based assays, stability & binding tests
Camel heavy-chain antibodies
Nanobodies are single-domain antibodies (~15 kDa) derived from camelid heavy-chain antibodies. Compared to conventional antibodies (~150 kDa), they reach hidden epitopes, remain stable across heat/pH swings, and can be expressed at scale in microbial systems. The class is clinically validated and growing.
Jamalone is a research platform that unites ethical biosourcing, multi-omics analysis, and AI design to explore how camel biology can inspire more stable, accessible therapeutics. It's where computational insight meets natural adaptation.
Jamalone is a research platform that unites ethical biosourcing, multi-omics analysis, and AI design to explore how camel biology can inspire more stable, accessible therapeutics. It's where computational insight meets natural adaptation.
